• New acquisition has goal of developing laser-based cancer proton therapy system

    HIL Applied Medical has acquired Nanolabz, which develops and fabricates smart targets for laser-based proton acceleration.
    June 7, 2016

    Proton therapy systems developer HIL Applied Medical (Jerusalem, Israel) has acquired Nanolabz (Reno, NV), which develops and fabricates smart targets for laser-based proton acceleration. HIL Applied Medical is developing a new class of ultra-compact, high-performance proton beam therapy systems for cancer based on high-intensity lasers and nano-engineered smart targetry.

    Related: Terawatt laser enables higher energies for particle acceleration in cancer therapy

    A proton beam is a form of focused radiation used to treat solid tumors. When compared to traditional radiation therapy (x-ray or photons), it reduces damage to surrounding healthy tissue by 2-6X, thereby reducing toxicities and improving patient survival and quality of life. Proton therapy is used routinely for treating many types of cancer—it is FDA-cleared and reimbursed by both federal and private insurers.

    For more information, please visit www.hilappliedmedical.com.

    Sign up for Laser Focus World Newsletters
    Get the latest news and updates.

    Voice Your Opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!